NCT00611351 2023-10-23Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerUniversity of NebraskaPhase 2 Completed5 enrolled 10 charts
NCT01269385 2020-06-23Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic LeukemiaMayo ClinicPhase 1/2 Completed22 enrolled 9 charts
NCT00049504 2017-05-17Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled 10 charts